Goflikicept Recruiting Phase 2 Trials for Familial Mediterranean Fever (FMF ) / FMF Treatment

Indications	Status	Purpose	Phase
DBCOND0067538 (Familial Mediterranean Fever (FMF )) DBCOND0075961 (FMF)	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT05092776	Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine	Goflikicept (DB16396)
NCT05190991	Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever	Goflikicept (DB16396)